Which Lipoprotein Measurements Are Clinically Useful?

dc.contributor.author	Pejic, Rade N.	eng
dc.contributor.author	Jamieson, Barbara	eng
dc.date.issued	2007	eng
dc.description.abstract	Emerging lipid risk factors for cardiovascular disease include lipoprotein remnants, lipoprotein (a), small LDL particles, HDL subspecies, apolipoprotein B, apolipoprotein A-I, and oxidized LDL. Measurement of these levels should not be used for routine cardiovascular risk screening. (Strength of Recommendation [SOR]: C, based on expert opinion and lack of clinical outcomes trials)	eng
dc.identifier.uri	http://hdl.handle.net/10355/3977	eng
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Clinical Inquiries, 2007 (MU)	eng
dc.relation.ispartofcommunity	University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	American family physician, 75, no. 03 (February 2007)	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject	cardiovascular disease	eng
dc.subject	lipid risk factors	eng
dc.subject	dyslipidemia	eng
dc.subject.lcsh	High density lipoproteins	eng
dc.subject.lcsh	Low density lipoproteins	eng
dc.subject.lcsh	Heart -- Diseases -- Prevention	eng
dc.title	Which Lipoprotein Measurements Are Clinically Useful?	eng
dc.type	Article	eng

Clinical Inquiries, 2007
The items in this collection constitute volume 56 of Clinical Inquiries.